Objectives: Acinetobacter baumannii outer membrane protein A (AbOmpA) is involved in bacterial pathogenesis. However, the role of AbOmpA in the antimicrobial resistance of A. baumannii has not been fully elucidated. This study aimed to investigate the role of the OmpA-like domain of AbOmpA in the antimicrobial resistance of A. baumannii.
Introduction
Acinetobacter baumannii causes a variety of nosocomial infections with a high risk of antimicrobial resistance. 1 Many clinical isolates of A. baumannii are resistant to many clinically available antimicrobial agents, including carbapenems. Besides the well-known acquired resistance mechanisms, A. baumannii expresses membrane proteins responsible for its intrinsic resistance to antimicrobial agents, including the permeability pore proteins and efflux pumps.
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Outer membrane protein A (OmpA) is a major b-barrel porin expressed in the outer membrane of Gram-negative bacteria. A. baumannii OmpA (AbOmpA) exhibits multiple functions in bacterial pathogenesis, including adherence to host cells, induction of host cell death and serum resistance. [5] [6] [7] In A. baumannii infection, overexpression of the ompA gene is clinically associated with development of pneumonia and bacteraemia, and patient mortality. 8 Even though AbOmpA functions have been unveiled in the pathogenesis of A. baumannii, the multifaceted functions of AbOmpA are still unknown, especially in antimicrobial resistance. The C-terminal OmpA-like domain of outer membrane proteins in Gram-negative bacteria is a globular protein facing the periplasmic space and it interacts non-covalently with peptidoglycan, which provides stability and cellular integrity. 9 However, the association of the OmpA-like domain of AbOmpA with antimicrobial resistance has not been studied. The present study aimed to determine the involvement of AbOmpA in the antimicrobial resistance of A. baumannii using the DompA mutant and OmpA-like domaindeleted mutant strains.
Materials and methods

Bacterial strains
A. baumannii ATCC 17978, MDR 1656-2 and their ompA deletion (DompA) mutants described in previous studies were used. 10, 11 A. baumannii ATCC 17978 with the OmpA-like domain of AbOmpA deleted (amino acids 223-356) and single-copy ompA-complemented strains of the DompA mutant of ATCC 17978 were generated (Supplementary Materials and methods, available as Supplementary data at JAC Online). The PCR primers and bacterial strains used in this study are in Tables S1 and S2, respectively. The WT ATCC 17978 and its mutant strains were checked to verify deletion or complementation of the ompA gene and expression of AbOmpA in the outer membrane (Supplementary Materials and methods and Figure S1 ).
Antimicrobial susceptibility testing
MICs were determined by the Etest method according to the manufacturer's instructions. Antimicrobial agents included aztreonam, ceftazidime, ciprofloxacin, colistin, gentamicin, imipenem, nalidixic acid, tetracycline, tigecycline and trimethoprim (bioMérieux, Marcy-l' Etoile, France). Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as quality control strains. An efflux pump inhibitor, PABN 12 (Sigma-Aldrich, St Louis, MO, USA), was added to Mueller-Hinton agar plates at a concentration of 20 mg/L. Interpretation of antimicrobial susceptibility was based on the guidelines of CLSI. 13 Antimicrobial susceptibility testing was performed in two independent experiments.
Results and discussion
Antimicrobial susceptibilities of the DompA mutants of A. baumannii
The MICs of antimicrobial agents for A. baumannii ATCC 17978, DompA mutant (HKD14) and ompA-complemented (OH3) strains were determined. The DompA mutant was more susceptible to trimethoprim (.5.33-fold) than the WT strain, but the remaining antimicrobial agents, except tigecycline, showed a ,2-fold decrease in the MICs for the DompA mutant ( Table 1) . The MICs of all antimicrobial agents determined for the ompA-complemented strain were the same as or similar to those for the WT strain (0.8-to 1.0-fold). The MICs of antimicrobial agents for MDR 1656-2 and its DompA mutant (HKD15) were determined. The HKD15 strain was more susceptible to trimethoprim (.4.0-fold) and tetracycline (2.29-fold) than the WT strain, but colistin, imipenem and tigecycline showed a ,2-fold decrease in the MICs for the HKD15 strain ( Table 1 ). The MICs of aztreonam, ceftazidime, gentamicin, ciprofloxacin and nalidixic acid were not changed between the 1656-2 and HKD15 strains. This may be due to the carriage of b-lactamases (bla ADC-31 , bla PER-1 and bla OXA-109 ) and aacA16, and a Ser83Leu mutation in the gyrA gene in the 1656-2 strain. 10 Our results showed that loss of AbOmpA in the outer membrane changed the MICs of antimicrobial agents for both ATCC 17978 and MDR 1656-2 strains, suggesting the involvement of AbOmpA in intrinsic resistance of A. baumannii.
Possible mechanism of AbOmpA in antimicrobial resistance of A. baumannii Sugawara and Nikaido 2 showed a 2-to 4-fold decrease in the MICs of ampicillin, benzylpenicillin, nitrocefin and novobiocin and an 8-fold decrease in the MIC of polymyxin B for the DompA mutant of A. baumannii ATCC 17978. However, the MICs of carbenicillin, cephalosporins, aztreonam, imipenem, tetracycline, chloramphenicol and gentamicin were not changed between the WT and DompA mutant strains. They explained that the increased susceptibility to lipophilic agents such as benzylpenicillin, nitrocefin and novobiocin in the DompA mutant was possibly due to the increased diffusion of drugs across the modified outer membrane. The absence of AbOmpA in the DompA mutant might result in empty spaces in the outer membrane and produce a modified phospholipid-filled lipid bilayer. Moreover, Sugawara and Nikaido 2 proposed that AbOmpA was the major non-specific slow porin in A. baumannii, because the permeability of hydrophilic cephalosporins was decreased 2-to 3-fold in the DompA mutant compared with the WT strain. In the present study, there was a ,2-fold decrease in the MICs of aztreonam, ceftazidime, gentamicin, imipenem and tetracycline for the DompA mutant of ATCC 17978. These results suggest that the reduction in the MICs of hydrophilic antimicrobial agents, including ceftazidime, ciprofloxacin, gentamicin, imipenem and nalidixic acid, for the DompA mutant is not strongly associated with the increased diffusion of drugs across the outer membrane, but it is possible that these antimicrobial agents can traverse the outer membrane through a non-specific slow porin (i.e. AbOmpA) in A. baumannii.
Another report, by Smani et al., 14 demonstrated that an ompAdisrupted mutant was more susceptible (2-fold) than the WT ATCC 17978 to aztreonam, chloramphenicol and nalidixic acid, which are efflux pump substrates. They proposed that AbOmpA might couple with inner membrane efflux pumps and participate in the extrusion of antimicrobial agents. Based on this observation, we determined the MICs of five antimicrobial agents for ATCC 17978 and MDR 1656-2 and their DompA mutant strains in the presence of PABN, a commonly assumed inhibitor of the resistance-nodulation-division (RND) efflux pumps. 12 A small decrease in the MICs of gentamicin, imipenem and nalidixic acid for ATCC 17978 and its DompA mutant was observed in the presence of PABN (Table 1) . A similar reduction in the MICs of imipenem and tetracycline for the 1656-2 strain and its DompA mutant was observed. These results suggest that PABN-sensitive efflux pumps for these antimicrobial agents play a role in the decreased MICs for the DompA mutant strains. Based on the MICs of antimicrobial agents for the WT and DompA mutant strains in the presence or absence of PABN, we speculate that AbOmpA is possibly associated with efflux pumps.
Three types of efflux systems have been described in A. baumannii: the RND family, the major facilitator superfamily (MFS) and the multidrug and toxic compound extrusion family. 15, 16 RND efflux pumps such as AdeABC, AdeIJK and AdeFGH are composed of an inner membrane transporter, a membrane fusion protein and an outer membrane channel protein. The inner membrane transporter and membrane fusion protein are specific for each RND efflux pump, whereas other outer membrane proteins can compensate for specific channel proteins. 17 A recent report by Wu et al. 18 showed that AdeK interacts with AbOmpA and AdeC. To investigate whether the OmpA-like domain of AbOmpA might associate with inner membrane transporters in RND efflux systems, the MICs of antimicrobial agents for WT ATCC 17978 and a mutant OH171 strain with the OmpA-like domain-deleted AbOmpA were compared. There was a 2-fold decrease in the MICs of aztreonam, colistin, gentamicin, imipenem and Role of AbOmpA in antimicrobial susceptibility JAC trimethoprim for the OH171 strain (Table 1) . Moreover, the OH171 strain was more susceptible to aztreonam, colistin, gentamicin, imipenem and tigecycline than the DompA mutant HKD14 strain. Aztreonam, gentamicin, imipenem, tigecycline and trimethoprim are substrates of the RND efflux pumps. 15 Our results suggest that the OmpA-like domain of AbOmpA is responsible for the susceptibility of A. baumannii ATCC 17978 to these antimicrobial agents. Tigecycline is transported by the MFS efflux pump system as well as the RND efflux system, 15, 19 which may result in either no difference or a very small difference in the MICs of these antimicrobial agents between ATCC 17978 and its ompA mutant strains. It is possible that the OmpA-like domain of AbOmpA interacts with inner membrane transporters of the RND efflux pumps, but the molecular interaction of the OmpA-like domain of AbOmpA with inner membrane transporters of the RND efflux systems should be determined, especially in AdeIJK, because AdeIJK contributes to intrinsic resistance to many antimicrobial agents. 16 The MIC results obtained in this study were very different from those of the previous report by Smani et al., 14 although the A. baumannii ATCC 17978 strain and Etest assay were the same in the two studies. Construction of the DompA mutant and the ompA-complemented strain was different between the two studies, which may have caused the difference in MIC values of antimicrobial agents between the two studies.
In conclusion, AbOmpA plays a role in the pathogenesis of A. baumannii. In addition, the present study shows the involvement of AbOmpA in intrinsic resistance to clinically important antimicrobial agents, including aztreonam, colistin, imipenem, gentamicin and trimethoprim, in A. baumannii through the OmpA-like domain. Further studies are needed to elucidate the interaction of AbOmpA with the RND efflux pumps at a molecular level. 
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